First Light Asset Management as of March 31, 2020
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 64 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Repro-Med Systems (KRMD) | 9.3 | $54M | 7.2M | 7.50 | |
| Oxford Immunotec Global | 6.4 | $38M | 4.1M | 9.26 | |
| Seaspine Holdings | 6.3 | $37M | 4.5M | 8.17 | |
| Halozyme Therapeutics (HALO) | 5.0 | $29M | 1.6M | 17.99 | |
| Immunomedics | 4.6 | $27M | 2.0M | 13.48 | |
| AtriCure (ATRC) | 4.3 | $25M | 751k | 33.59 | |
| Caredx (CDNA) | 4.0 | $24M | 1.1M | 21.83 | |
| Pfenex | 3.5 | $21M | 2.3M | 8.82 | |
| Model N (MODN) | 3.5 | $21M | 926k | 22.21 | |
| Tandem Diabetes Care (TNDM) | 3.1 | $18M | 286k | 64.35 | |
| Vapotherm | 3.0 | $18M | 930k | 18.83 | |
| Intersect Ent | 2.9 | $17M | 1.5M | 11.85 | |
| iShares Dow Jones US Medical Dev. (IHI) | 2.9 | $17M | 7.6k | 2253.30 | |
| NeoGenomics (NEO) | 2.9 | $17M | 611k | 27.61 | |
| Codexis (CDXS) | 2.8 | $17M | 1.5M | 11.16 | |
| Teva Pharmaceutical Industries (TEVA) | 2.8 | $17M | 1.8M | 8.98 | |
| Insmed (INSM) | 2.8 | $16M | 1.0M | 16.03 | |
| Iovance Biotherapeutics (IOVA) | 2.7 | $16M | 531k | 29.94 | |
| Ultragenyx Pharmaceutical (RARE) | 2.6 | $15M | 343k | 44.43 | |
| United Therapeutics Corporation (UTHR) | 2.1 | $12M | 129k | 94.83 | |
| Alexion Pharmaceuticals | 1.9 | $11M | 123k | 89.79 | |
| Ionis Pharmaceuticals (IONS) | 1.6 | $9.3M | 196k | 47.28 | |
| BioMarin Pharmaceutical (BMRN) | 1.5 | $8.9M | 105k | 84.50 | |
| Heron Therapeutics (HRTX) | 1.4 | $8.1M | 691k | 11.74 | |
| Si-bone (SIBN) | 1.4 | $8.1M | 679k | 11.95 | |
| Tabula Rasa Healthcare | 1.2 | $7.0M | 134k | 52.29 | |
| Myokardia | 1.0 | $5.6M | 120k | 46.88 | |
| Veracyte (VCYT) | 0.9 | $5.4M | 224k | 24.31 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $5.4M | 23k | 237.95 | |
| Quidel Corporation | 0.9 | $5.2M | 54k | 97.81 | |
| Zymeworks | 0.9 | $5.1M | 145k | 35.47 | |
| Bio-techne Corporation (TECH) | 0.8 | $4.8M | 25k | 189.62 | |
| Orthopediatrics Corp. (KIDS) | 0.8 | $4.8M | 120k | 39.64 | |
| Simulations Plus (SLP) | 0.7 | $4.3M | 123k | 34.92 | |
| Bluebird Bio (BLUE) | 0.7 | $4.2M | 92k | 45.95 | |
| Arena Pharmaceuticals | 0.7 | $3.9M | 93k | 42.00 | |
| Ligand Pharmaceuticals In (LGND) | 0.6 | $3.3M | 45k | 72.72 | |
| Amarin Corporation (AMRN) | 0.5 | $3.0M | 758k | 4.00 | |
| Epizyme | 0.5 | $3.0M | 195k | 15.51 | |
| Glaukos (GKOS) | 0.5 | $2.8M | 91k | 30.86 | |
| Adverum Biotechnologies | 0.4 | $2.4M | 242k | 9.77 | |
| LHC | 0.3 | $2.0M | 14k | 140.21 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.3 | $1.8M | 17k | 107.76 | |
| Invesco S&p Smallcap Health Etf (PSCH) | 0.3 | $1.8M | 17k | 103.38 | |
| Health Care SPDR (XLV) | 0.3 | $1.6M | 18k | 88.59 | |
| LeMaitre Vascular (LMAT) | 0.2 | $1.2M | 48k | 24.91 | |
| Itamar Med | 0.2 | $960k | 82k | 11.78 | |
| Global Blood Therapeutics In | 0.1 | $577k | 11k | 51.06 | |
| Gw Pharmaceuticals Plc ads | 0.1 | $560k | 6.4k | 87.50 | |
| Centene Corporation (CNC) | 0.1 | $530k | 8.9k | 59.44 | |
| Dynatronics | 0.1 | $389k | 450k | 0.86 | |
| Allergan | 0.1 | $382k | 2.2k | 177.10 | |
| Merck & Co (MRK) | 0.1 | $327k | 4.2k | 77.00 | |
| Abbvie (ABBV) | 0.1 | $313k | 4.1k | 76.08 | |
| Novartis (NVS) | 0.0 | $291k | 3.5k | 82.32 | |
| Sanofi-Aventis SA (SNY) | 0.0 | $291k | 6.7k | 43.76 | |
| Health Catalyst (HCAT) | 0.0 | $290k | 11k | 26.13 | |
| Johnson & Johnson (JNJ) | 0.0 | $283k | 2.2k | 130.96 | |
| Pfizer (PFE) | 0.0 | $276k | 8.5k | 32.59 | |
| Baxter International (BAX) | 0.0 | $265k | 3.3k | 81.34 | |
| Amgen (AMGN) | 0.0 | $221k | 1.1k | 202.38 | |
| Direxion Shs Etf Tr Daily S&p Biotec | 0.0 | $217k | 15k | 14.09 | |
| Hill-Rom Holdings | 0.0 | $213k | 2.1k | 100.42 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.0 | $205k | 10k | 20.17 |
